By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ambrx, Inc. 

10975 North Torrey Pines Road

La Jolla  California  92037  U.S.A.
Phone: 858-875-2400 Fax: 858-453-4511



Company News
Ambrx, Inc. And MabSpace Biosciences To Collaborate On Novel Antibody Drug Conjugates 1/5/2017 11:07:50 AM
With New Owners, Ambrx, Inc. Aims To Challenge Genentech (RHHBY) 11/3/2016 7:44:23 AM
Ambrx, Inc. Closes $45M Round Of Financing 8/4/2016 7:27:14 AM
Wuxi Biologics Congratulates Ambrx, Inc. And ZMC For Successful Dosing Of A Novel Antibody-Drug Conjugate In Australia 3/25/2016 7:42:48 AM
Ambrx, Inc. And Zhejiang Medicine Co. Ltd Initiated ARX788 First-In-Human Phase I Clinical Trial In Cancer Patients 3/22/2016 6:18:25 AM
Ambrx, Inc. Announces New Chief Medical Officer 11/16/2015 9:02:39 AM
Ambrx, Inc. Names Dr. Tiecheng Qiao As CEO, Dr. Feng Tian As CSO 6/22/2015 6:08:11 AM
Week In Review: Fosun Pharma, WuXi PharmaTech Co., Ltd. Acquire San Diego's Ambrx, Inc. 5/26/2015 8:13:38 AM
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, And WuXi PharmaTech Co., Ltd. To Jointly Acquire U.S. Innovative Biotechnology Company Ambrx, Inc. 5/22/2015 6:27:59 AM
San Diego's Ambrx, Inc. Withdraws Planned $86 Million IPO, Citing Market Conditions 7/1/2014 6:30:38 AM